TrialEndocrine journal2026

Efficacy and safety of once-weekly somatrogon following up to 4 years of treatment in Japanese children with growth hormone deficiency: results from an open-label extension of a phase 3 study.

Reiko Horikawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.